Table 3.
Concentration of TPFs in medium conditioned by tumor cells (TCM), by doxorubicin-treated tumor cells (DTCM) and in fresh medium (FM) supplemented with tumor cell lysate
Media | Cytokines (pg/1×106cells) | ||||
---|---|---|---|---|---|
IL-6 | CXCL8 | CCL2 | CXCL1 | VEGF | |
TCM | 59,044 | 13,934 | 178 | 182 | 2098 |
DTCM | 108,263* | 198,000* | 271* | 447* | 2968* |
FM + tumor cells lysates | 122 | 68 | 12 | 78 | 4 |
FM + drug-treated cell lysates | 150 | 67 | 10 | 60 | 4 |
H460 tumor cells were cultured in a 6-well plate (2×106/well/2 ml) in the presence or absence of doxorubicin (0.125 μg/ml) for 24h. Supernatants were collected, remaining cells were harvested and sonicated, and tumor lysates were centrifuged to remove cell debris. Tumor cell lysates (equivalent to 1×106tumor cells) were added to 1 ml of fresh culture medium. The concentrations of cytokines in media conditioned by untreated tumor cells (TCM), doxorubicin-treated tumor cells (DTCM) or fresh media (FM) conditioned by tumor lysates were determined using a Luminex multiplex assay.
Significantly (p<0.05) differ from other groups.